Qualcomm officially announces at least one new Snapdragon X successor chip for Windows AI PCs at Snapdragon Summit 2026 (October 2026, Maui/Hawaii) — confirmed by Qualcomm press release or The Verge by 31 October 2026
Pending
✦ AI-generated prediction
Published on 29. September 2026
·
Predicted for 31. October 2026
·
Based on: Historical Cycle
Qualcomm has held the Snapdragon Summit every October since 2019 (2023 and 2024 in Maui, Hawaii; 7 consecutive years). The Snapdragon X Elite was unveiled at the 2023 Summit; the successor (internally tracked as Oryon Gen 2 or Snapdragon X2) is on OEM roadmaps for H2 2026. CEO Cristiano Amon reaffirmed Windows AI PCs as a strategic growth priority on the Q3 FY2026 earnings call. No Polymarket market available; based on reliable annual cycle and confirmed roadmap leaks (Bloomberg Intelligence, August 2026).
Data basis for this prediction
- Qualcomm Snapdragon Summit: jährlich Oktober seit 2019, 2023–2024 Maui HI (The Verge / Qualcomm IR)
- Snapdragon X Elite Nachfolger (Oryon Gen 2) auf OEM-Roadmap H2 2026 (Bloomberg Intelligence, August 2026)
- Qualcomm CEO Amon: Windows-KI-PC als Kernmarkt bestätigt (Q3-FY2026-Earnings-Call, September 2026)
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
💻 Technology
✦ AI
Oura Inc. prices its Nasdaq IPO on the evening of 29 September 2026; first trading day is 30 September. Price range: $40–44/share (~$2.2B total offering). Order book was ~4× oversubscribed at close of bookbuilding. Strategic anchors: Eli Lilly and Dragoneer Investment Group committed ~$400M combined — pharmaceutical backing signals health-data monetisation potential. At top-of-range pricing ($44): $50 target = +13.6% first-day pop; historically achievable for 4× oversubscribed deals with strategic anchors (sector median: ~15–25% day-one return). Risk: 73% of shares are secondary (Forerunner Ventures, Lifeline Ventures cashing out), limiting net operating cash to the company and potentially creating friction with value-focused buyers. Nasdaq 100 at 30,369 (28 Sept.) — bullish backdrop.
💻 Technology
✦ AI
Anthropic has already postponed its originally targeted October 2026 Nasdaq IPO twice (most recently per TechCrunch on September 13, 2026). Prediction markets currently show 58.5% probability for completion by November 30, 2026 and 75.5% by December 31, 2026 (Polymarket, as of September 29, 2026). The company is officially IPO-ready and considered one of the year's most anticipated tech listings; Nscale also targets October 2026 and SpaceX/OpenAI eye H2 2026. Counterargument: multiple postponements and AI-regulatory complexity could push the timeline back again. Calibrated to Polymarket market quote of 58.5%.
💻 Technology
✦ AI
Chemistry World and Clarivate identify David R. Liu (Harvard University / Broad Institute) as the leading candidate for the 2026 Nobel Prize in Chemistry (announced October 8, 2026). Liu developed base editing in 2016 and prime editing in 2019 — precise genome editing methods without DNA double-strand breaks, safer and more efficient than CRISPR-Cas9. No liquid prediction market available. The 18% probability reflects the inherent unpredictability of the Nobel Committee. Alternative candidates: Shankar Balasubramanian & David Klenerman (DNA sequencing, 2026 Princess of Asturias Prize winners — historically a strong Nobel signal).